Ítalo Costa Monteiro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ítalo Costa Monteiro has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Tiago Lima Sampaio
Universidade Federal do Ceará
3 shared publications - Antonia Gabriella de Souza Freitas
Universidade Federal do Ceará
2 shared publications - Bruna Ribeiro Duque
Universidade Federal do Ceará
2 shared publications - Izabell Maria Martins Teixeira
Universidade Federal do Ceará
2 shared publications - Mac Dionys Rodrigues da Costa
Universidade Federal do Ceará
2 shared publications - Natasha Maria Lima Pinheiro
Universidade Federal do Ceará
2 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by APESC - Associacao Pro-Ensino em Santa Cruz do Sul in Revista de Epidemiologia e Controle de Infecção
- Vol. 16
Bomba de efluxo MexAB-OprM como fator de resistência antimicrobiana em Pseudomonas aeruginosa: revisão integrativa
Background and Objectives: Pseudomonas aeruginosa is an opportunistic pathogen and a major cause of healthcare-associated infections. The World Health Organization (WHO) has identified this pathogen as a critical priority in the context of antimicrobial resistance. Among its resistance mechanisms, the MexAB-OprM efflux pump plays an important role in reducing susceptibility to antimicrobial agents. This integrative review aimed to examine the relationship between the MexAB-OprM efflux pump and antimicrobial resistance in P. aeruginosa, with the broader goal of contributing to the development of effective clinical management strategies. Content: A literature search identified 113 records. Studies were screened based on predefined eligibility criteria. Reviews, meta-analyses, articles for which the full text was unavailable, and studies that did not focus on P. aeruginosa and the MexAB-OprM efflux pump were excluded during the initial screening. In the subsequent stage, studies that did not specifically address the role of this efflux system in antimicrobial resistance were also excluded. Following the selection process, 24 studies were included in the review. The findings indicate that the MexAB-OprM efflux pump contributes to antimicrobial resistance in P. aeruginosa. Moreover, its contribution is not independent of other resistance mechanisms but frequently occurs in conjunction with them, particularly β-lactamase production. Conclusion: MexAB-OprM-mediated resistance poses a significant challenge to the clinical management of infections caused by multidrug-resistant P. aeruginosa, particularly in healthcare settings. Further research into the role of this efflux system, alongside a critical assessment of current treatment protocols, is warranted to improve therapeutic strategies and mitigate the impact of antimicrobial resistance.
- 6 November 2026
- Published by APESC - Associacao Pro-Ensino em Santa Cruz do Sul in Revista de Epidemiologia e Controle de Infecção
- Vol. 16
Open AccessBomba de efluxo MexAB-OprM como fator de resistência antimicrobiana em Pseudomonas aeruginosa: revisão integrativa
Background and Objectives: Pseudomonas aeruginosa is an opportunistic pathogen and a major cause of healthcare-associated infections. The World Health Organization (WHO) has identified this pathogen as a critical priority in the context of antimicrobial resistance. Among its resistance mechanisms, the MexAB-OprM efflux pump plays an important role in reducing susceptibility to antimicrobial agents. This integrative review aimed to examine the relationship between the MexAB-OprM efflux pump and antimicrobial resistance in P. aeruginosa, with the broader goal of contributing to the development of effective clinical management strategies. Content: A literature search identified 113 records. Studies were screened based on predefined eligibility criteria. Reviews, meta-analyses, articles for which the full text was unavailable, and studies that did not focus on P. aeruginosa and the MexAB-OprM efflux pump were excluded during the initial screening. In the subsequent stage, studies that did not specifically address the role of this efflux system in antimicrobial resistance were also excluded. Following the selection process, 24 studies were included in the review. The findings indicate that the MexAB-OprM efflux pump contributes to antimicrobial resistance in P. aeruginosa. Moreover, its contribution is not independent of other resistance mechanisms but frequently occurs in conjunction with them, particularly β-lactamase production. Conclusion: MexAB-OprM-mediated resistance poses a significant challenge to the clinical management of infections caused by multidrug-resistant P. aeruginosa, particularly in healthcare settings. Further research into the role of this efflux system, alongside a critical assessment of current treatment protocols, is warranted to improve therapeutic strategies and mitigate the impact of antimicrobial resistance.
- Open Access
- 2 January 2026
- Published by Instituto para o Desenvolvimento da Educacao in Journal of Health & Biological Sciences
- Vol. 14 (1) , e6478
Susceptibility profile of Staphylococcus aureus isolates in blood cultures from a tertiary hospital - comparison of methods for determination of minimum inhibitory concentration of vancomycin
Objective: to evaluate the antimicrobial susceptibility profile of Staphylococcus aureus isolates from blood cultures and compare methods for determiningthe minimum inhibitory concentration (MIC) of vancomycin. Methods: an observational study conducted in a tertiary hospital, involving 62 clinical isolates of S. aureus. In addition, the MIC of vancomycin was determined using the Etest®, broth microdilution (BMD), and Vitek® automated system methods. Clinically relevant antimicrobial susceptibility profiles were evaluated, and agreement between methods was analyzed by statistical correlationusing IBM-SPSS® software. The study was approved by the hospital's Research Ethics Committee under registration number 5.557.687/2022. Results: methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) isolates were susceptible to vancomycin, teicoplanin, linezolid, daptomycin, and tigecycline. A better correlation was observed between the vancomycin MIC values obtained by Vitek®2 and BMD compared to Etest®. However, Vitek®2 tended to overestimate MIC compared to BMD. Conclusion: the results indicate the importance of using complementary methods to validate high vancomycin MIC values, contributing to more appropriate therapeutic decisions and the prevention of bacterial resistance.
- 2 January 2026
- Published by Instituto para o Desenvolvimento da Educacao in Journal of Health & Biological Sciences
- Vol. 14 (1) , e6478
Open AccessSusceptibility profile of Staphylococcus aureus isolates in blood cultures from a tertiary hospital - comparison of methods for determination of minimum inhibitory concentration of vancomycin
Objective: to evaluate the antimicrobial susceptibility profile of Staphylococcus aureus isolates from blood cultures and compare methods for determiningthe minimum inhibitory concentration (MIC) of vancomycin. Methods: an observational study conducted in a tertiary hospital, involving 62 clinical isolates of S. aureus. In addition, the MIC of vancomycin was determined using the Etest®, broth microdilution (BMD), and Vitek® automated system methods. Clinically relevant antimicrobial susceptibility profiles were evaluated, and agreement between methods was analyzed by statistical correlationusing IBM-SPSS® software. The study was approved by the hospital's Research Ethics Committee under registration number 5.557.687/2022. Results: methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) isolates were susceptible to vancomycin, teicoplanin, linezolid, daptomycin, and tigecycline. A better correlation was observed between the vancomycin MIC values obtained by Vitek®2 and BMD compared to Etest®. However, Vitek®2 tended to overestimate MIC compared to BMD. Conclusion: the results indicate the importance of using complementary methods to validate high vancomycin MIC values, contributing to more appropriate therapeutic decisions and the prevention of bacterial resistance.
- Open Access
- 28 October 2025
- Published by Wiley
SUSCEPTIBILITY PROFILE OF Staphylococcus aureus BLOOD ISOLATES AND COMPARISON OF VANCOMYCIN MIC DETERMINATION METHODS
Introduction: The existence of inconsistencies in the vancomycin minimum inhibitory concentration (MIC) for Staphylococcus aureus obtained by automated methods when compared with the results obtained by methods such as Etest ® and broth microdilution (BMD) shows the necessity of evaluate and compare these results. Materials and Methods: Regarding that, vancomycin MIC, and susceptibility profiles of 62 S. aureus isolates from blood cultures were all determined using the Etest ® , BMD, and Vitek ® 2 methods, these three methods evaluating their susceptibility profiles. Results and Discussion: Methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) S. aureus strains showed susceptibility to vancomycin, teicoplanin, linezolid, daptomycin and tigecycline. Vitek ® 2 (r = 0.6975, p® (r = 0.2563, p® 2 was overestimated by MIC compared to BMD. Conclusion: Therefore, it is recommended to implement complementary methods to confirm if the high vancomycin MIC results are valid, thereby avoiding inappropriate use of antibiotics and the increase of resistance.
- 28 October 2025
- Published by Wiley
Open AccessSUSCEPTIBILITY PROFILE OF Staphylococcus aureus BLOOD ISOLATES AND COMPARISON OF VANCOMYCIN MIC DETERMINATION METHODS
Introduction: The existence of inconsistencies in the vancomycin minimum inhibitory concentration (MIC) for Staphylococcus aureus obtained by automated methods when compared with the results obtained by methods such as Etest ® and broth microdilution (BMD) shows the necessity of evaluate and compare these results. Materials and Methods: Regarding that, vancomycin MIC, and susceptibility profiles of 62 S. aureus isolates from blood cultures were all determined using the Etest ® , BMD, and Vitek ® 2 methods, these three methods evaluating their susceptibility profiles. Results and Discussion: Methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) S. aureus strains showed susceptibility to vancomycin, teicoplanin, linezolid, daptomycin and tigecycline. Vitek ® 2 (r = 0.6975, p® (r = 0.2563, p® 2 was overestimated by MIC compared to BMD. Conclusion: Therefore, it is recommended to implement complementary methods to confirm if the high vancomycin MIC results are valid, thereby avoiding inappropriate use of antibiotics and the increase of resistance.